Duke Cancer Institute

32.6k citations
1.3k papers ·

Impact in

  • Oncology top 10%
    • Cancer survivorship and care
    • Cancer Immunotherapy and Biomarkers
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer survivorship and care 67
    • Cancer Immunotherapy and Biomarkers 58
    • Prostate Cancer Treatment and Research 90
    • Prostate Cancer Diagnosis and Treatment 63
    • Lung Cancer Treatments and Mutations 46

Duke Cancer Institute

1.0k papers receiving 25.0k citations

Peers

Duke Cancer Institute
Comparison fields: 5 of 196
  • Oncology 8.9k
  • Cancer Research 3.5k
  • Pulmonary and Respiratory Medicine 6.5k
  • Otorhinolaryngology 474
  • Hematology 1.2k
Replace Carolinas Healthcare System with:
Carolinas Healthcare System United States
IQVIA (United States) United States
MUSC Hollings Cancer Center United States
RTI Health Solutions United States
Levine Cancer Institute United States
The Coordinating Center United States
LabCorp (United States) United States
Temple University Health System United States
Integrated Oncology (United States) United States
Information Management Services United States
Duke Cancer Institute relative to Carolinas Healthcare System United States Carolinas Healthcare System's profile →
Citations per field
00.5×1.5×2.0×
Carolinas Healthcare System · 1×
Citations per year

Countries citing scholars working at Duke Cancer Institute

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Duke Cancer Institute. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Duke Cancer Institute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duke Cancer Institute more than expected).

Fields of papers published by authors at Duke Cancer Institute

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Duke Cancer Institute at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Duke Cancer Institute at the time of their publication.

About Duke Cancer Institute

In recent decades, authors affiliated with Duke Cancer Institute have published 1.3k papers, which have received a total of 32.6k indexed citations . Scholars at this organization have produced 342 papers in Oncology, 283 papers in Pulmonary and Respiratory Medicine, 103 papers in Cancer Research, 73 papers in Hematology and 25 papers in Otorhinolaryngology on the topics of Prostate Cancer Treatment and Research (90 papers), Palliative Care and End-of-Life Issues (81 papers), Childhood Cancer Survivors' Quality of Life (78 papers), Cancer survivorship and care (67 papers), Prostate Cancer Diagnosis and Treatment (63 papers), Cancer Immunotherapy and Biomarkers (58 papers), Economic and Financial Impacts of Cancer (54 papers) and Lung Cancer Treatments and Mutations (46 papers). Their work is cited by papers focused on Oncology (8.9k citations), Cancer Research (3.5k citations), Pulmonary and Respiratory Medicine (6.5k citations), Otorhinolaryngology (474 citations) and Hematology (1.2k citations). Authors at Duke Cancer Institute collaborate with scholars in United States, India and Canada and have published in prestigious journals including Cancer, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics, Gynecologic Oncology and Journal of Pain and Symptom Management. Some of Duke Cancer Institute's most productive authors include S. Yousuf Zafar, Thomas William LeBlanc, Andrew J. Armstrong, Lee W. Jones, Julie Ann Sosa, Amy P. Abernethy, Arif H. Kamal, Samantha Marie Thomas, Gary H. Lyman and Thomas E. Stinchcombe.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact